Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective ag...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/578434f27eb14ee59a138eb6fea5d128 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:578434f27eb14ee59a138eb6fea5d128 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:578434f27eb14ee59a138eb6fea5d1282021-11-14T04:30:33ZToward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery0753-332210.1016/j.biopha.2021.112416https://doaj.org/article/578434f27eb14ee59a138eb6fea5d1282022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221012026https://doaj.org/toc/0753-3322Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective agents. Cell-derived nanovesicles (CDNs), known for exosomes or extracellular vesicles (EVs), are biological nanoparticles with multiple functions. Compared to the artificial counterpart, CDNs hold great potential in drug delivery given the higher stability, superior biocompatibility and the lager capability of encapsulating bioactive molecules. Here, we provide a bench-to-bedside review of CDNs-based nanoplatform, including the bio-origin, preparation, characterization and functionalization. Beyond that, the focus is laid on the therapeutic effect of CDNs-mediated drug delivery for natural products. The state-of-art development as well as some pre-clinical applications of using CDNs for disease treatment is also summarized. It is highly expected that the continuing development of CDNs-based delivery systems will further promote the clinical utilization and translation of phyto-nanomedicines.Chaoxiang ChenJialin WangMengdi SunJian LiHui-Min David WangElsevierarticleCell-derived nanovesicles (CDNs)Extracellular vesicles (EVs)Natural productsNanoparticlesDeliveryTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112416- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Cell-derived nanovesicles (CDNs) Extracellular vesicles (EVs) Natural products Nanoparticles Delivery Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Cell-derived nanovesicles (CDNs) Extracellular vesicles (EVs) Natural products Nanoparticles Delivery Therapeutics. Pharmacology RM1-950 Chaoxiang Chen Jialin Wang Mengdi Sun Jian Li Hui-Min David Wang Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
description |
Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective agents. Cell-derived nanovesicles (CDNs), known for exosomes or extracellular vesicles (EVs), are biological nanoparticles with multiple functions. Compared to the artificial counterpart, CDNs hold great potential in drug delivery given the higher stability, superior biocompatibility and the lager capability of encapsulating bioactive molecules. Here, we provide a bench-to-bedside review of CDNs-based nanoplatform, including the bio-origin, preparation, characterization and functionalization. Beyond that, the focus is laid on the therapeutic effect of CDNs-mediated drug delivery for natural products. The state-of-art development as well as some pre-clinical applications of using CDNs for disease treatment is also summarized. It is highly expected that the continuing development of CDNs-based delivery systems will further promote the clinical utilization and translation of phyto-nanomedicines. |
format |
article |
author |
Chaoxiang Chen Jialin Wang Mengdi Sun Jian Li Hui-Min David Wang |
author_facet |
Chaoxiang Chen Jialin Wang Mengdi Sun Jian Li Hui-Min David Wang |
author_sort |
Chaoxiang Chen |
title |
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
title_short |
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
title_full |
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
title_fullStr |
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
title_full_unstemmed |
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery |
title_sort |
toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (cdns) for natural product delivery |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/578434f27eb14ee59a138eb6fea5d128 |
work_keys_str_mv |
AT chaoxiangchen towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery AT jialinwang towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery AT mengdisun towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery AT jianli towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery AT huimindavidwang towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery |
_version_ |
1718429957578817536 |